Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.55B | 2.65B | 2.72B | 2.76B | 2.75B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.55B | 2.65B | 2.72B | 2.76B | 2.75B |
| Cost of Revenue | 1.43B | 1.46B | 1.47B | 1.47B | 1.45B |
| Gross Profit | 1.13B | 1.19B | 1.25B | 1.29B | 1.30B |
| SG&A Expenses | 1.02B | 1.04B | 1.06B | 1.07B | 1.07B |
| Depreciation & Amortization | 92.66M | 116.92M | 95.21M | 73.43M | 52.15M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.54B | 2.62B | 2.63B | 2.62B | 2.57B |
| Operating Income | 11.89M | 32.16M | 90.77M | 146.61M | 180.93M |
| Income Before Tax | -148.66M | -115.48M | -112.80M | -101.95M | -396.02M |
| Income Tax Expenses | -25.72M | -4.89M | -7.46M | 729.00K | 29.08M |
| Earnings from Continuing Operations | -122.94 | -110.59 | -105.34 | -102.68 | -425.10 |
| Earnings from Discontinued Operations | -48.62M | -191.55M | -976.79M | -997.96M | -915.33M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -171.56M | -302.14M | -1.08B | -1.10B | -1.34B |
| EBIT | 11.89M | 32.16M | 90.77M | 146.61M | 180.93M |
| EBITDA | 208.13M | 253.57M | 289.47M | 326.47M | 425.59M |
| EPS Basic | -2.24 | -3.92 | -14.06 | -14.30 | -17.40 |
| Normalized Basic EPS | -0.99 | -0.76 | -0.37 | 0.15 | 0.20 |
| EPS Diluted | -2.24 | -3.93 | -14.06 | -14.30 | -17.40 |
| Normalized Diluted EPS | -0.99 | -0.76 | -0.37 | 0.15 | 0.20 |
| Average Basic Shares Outstanding | 306.74M | 307.11M | 307.35M | 308.19M | 308.66M |
| Average Diluted Shares Outstanding | 306.74M | 307.11M | 307.35M | 308.19M | 308.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |